The Impact of Cardio-Renal-Metabolic Profile in Dilated Cardiomyopathy

Tamim Akbari1,2, Daniel J Hammersley1,2,3, Clarice Yau-Yee May2

  • 1Royal Brompton and Harefield Hospitals, Part of Guy's and St Thomas' NHS Foundation Trust, London, UK.

PubMed

Insights

Dilated cardiomyopathy patients often have metabolic syndrome and renal disease, worsening prognosis. Optimizing cardio-renal-metabolic health is crucial for better outcomes in these complex cases.

Area of Science:

  • Cardiology
  • Nephrology
  • Metabolic Diseases

Background:

  • Dilated cardiomyopathy is a major cause of heart failure globally.
  • Aging populations and increasing multimorbidity exacerbate heart failure challenges.

Purpose of the Study:

  • To describe the prevalence of metabolic syndrome and renal failure in dilated cardiomyopathy patients.
  • To explore common underlying mechanisms and evaluate outcomes.
  • To highlight novel therapeutic strategies for this patient group.

Main Methods:

  • This is a review article.
  • It synthesizes current literature on dilated cardiomyopathy, metabolic syndrome, and renal disease.
  • Focuses on pathophysiological pathways and treatment strategies.

Main Results:

  • A significant number of dilated cardiomyopathy patients present with concurrent metabolic syndrome and renal disease.
  • This multimorbidity is associated with a worse prognosis and complex treatment challenges.
  • Shared pathophysiological pathways complicate management.

Conclusions:

  • Optimizing the cardio-renal-metabolic profile is essential for managing dilated cardiomyopathy.
  • New therapeutic strategies targeting shared pathways are needed to improve patient outcomes.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
534
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
565
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
651
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
700
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K